Established in 2019, RDNZ's Round Table of Companies is a group of pharmaceutical companies with a common interest in rare disorders and orphan drug development. The Round Table of Companies holds two meetings annually to discuss topics relevant to the development of orphan drugs and treatments for rare disorders in New Zealand. 

RDNZ Working with Pharmaceutical Industry policy 2019

VertexAlexionBiomarinMax healthAmicusTakedaBiogen